This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
BrightSpring Health Services, Inc. (BTSG) delivered earnings and revenue surprises of +15.79% and +5.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
5 Broker-Loved Stocks to Monitor Closely Amid Volatility
by Maharathi Basu
Brokers favor BTSG, ADM, DK, DINO and AN, given their strong ratings, earnings momentum and valuations despite market volatility.
Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Organon (OGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
BrightSpring Health Services, Inc. (BTSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is BrightSpring Health Services, Inc. (BTSG) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how BrightSpring Health Services, Inc. (BTSG) and Incyte (INCY) have performed compared to their sector so far this year.
Down 10.4% in 4 Weeks, Here's Why You Should You Buy the Dip in BrightSpring Health Services, Inc. (BTSG)
by Zacks Equity Research
The heavy selling pressure might have exhausted for BrightSpring Health Services, Inc. (BTSG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
5 Stocks Brokers Adore Even as Economic Uncertainty Lingers
by Maharathi Basu
Broker-backed picks like BTSG, GXO, BV, BLMN and ADM stand out as volatility rises and market uncertainty clouds rate cut timing.
Ensign Group Boosts U.S. Presence With Idaho and Texas Facility Buyouts
by Zacks Equity Research
ENSG adds Idaho and Texas facilities to its skilled nursing facility and real estate portfolios and earns an opportunity to boost revenues by catering to growing patient volumes.
Centene Pulls 2025 Guidance as Marketplace Growth Falters
by Zacks Equity Research
CNC pulls its 2025 forecast after a $1.8B risk adjustment shortfall. Also, weak Marketplace growth shakes investor confidence.
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment
by Zacks Equity Research
CI to cover RhinAer for chronic rhinitis starting Sept. 15, expanding access to a minimally invasive, office-based treatment.
BTSG vs. OPCH: Which Home Infusion Stock is a Better Buy Now?
by Urmimala Biswas
BTSG surges with 33% infusion growth and stronger EPS gains, making it a more compelling pick than OPCH right now.
BTSG Raises 2025 Financial Outlook: What's Backing It?
by Sridatri Sarkar
BrightSpring boosts 2025 guidance as Pharmacy and Provider segments post strong gains and margin initiatives take hold.
Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds?
by Sridatri Sarkar
BTSG faces margin pressure, but strong first-quarter gains in Pharmacy Solution and Provider Services lift confidence.
Zacks Industry Outlook Highlights CVS Health, BrightSpring Health Services and GeneDx
by Zacks Equity Research
CVS, BrightSpring, and GeneDx are tapping into AI, staffing trends, and precision medicine to drive future healthcare gains.
Are Options Traders Betting on a Big Move in BrightSpring Stock?
by Zacks Equity Research
Investors need to pay close attention to BTSG stock based on the movements in the options market lately.
3 Medical Services Stocks Capitalizing on the Healthcare AI Boom
by Urmimala Biswas
CVS, BTSG and WGS are three medical services stocks tapping into AI and tech-driven care to boost diagnostics, cut costs and drive growth in 2025.
Zacks.com featured highlights include BrightSpring Health Services, Allegiant Travel, CVR Energy, Alta Equipment Group and Cracker Barrel Old Country Store
by Zacks Equity Research
BTSG, ALGT, CVI, ALTG and CBRL earn broker favor as inflation cools and consumer confidence shows signs of revival.
5 Broker-Favored Stocks to Watch Amid Cooling Inflation
by Maharathi Basu
With inflation easing and consumer confidence rebounding, brokers favor stocks like BTSG, ALGT, CVI, ALTG and CBRL.
BrightSpring's Home Health Arm Soars: What's Powering Growth?
by Sridatri Sarkar
BTSG's Home Health Care Q1 2025 sales surge 21%, fueled by Medicare Advantage gains and high patient satisfaction.
BrightSpring Soars to All-Time High on Quality Strength: Still a Buy?
by Urmimala Biswas
BTSG stock hits an all-time high with a 120% gain as soaring quality ratings and strong Q1 results fuel investor confidence.
BrightSpring's Care Ratings Climb: Is Its Lead Sustainable?
by Sridatri Sarkar
BTSG boosts care quality with tech upgrades, earning top ratings and patient satisfaction across all segments.
Danaher Partners With AstraZeneca to Support Precision Medicine
by Zacks Equity Research
DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient selection and making advanced tests accessible worldwide.
5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost
by Maharathi Basu
Broker-favored picks like BYON, BTSG, ACDVF, EBS, and ADNT are worth monitoring amid EU tariff delay and rising consumer confidence.
Despite Fast-paced Momentum, BrightSpring Health Services, Inc. (BTSG) Is Still a Bargain Stock
by Zacks Equity Research
BrightSpring Health Services, Inc. (BTSG) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Are Medical Stocks Lagging Amedisys (AMED) This Year?
by Zacks Equity Research
Here is how Amedisys (AMED) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.